X

NewsRoom Articles

MindWave Innovations Inc. (NYSE American: APUS) Is Helping Corporations Hold, Manage, and Generate Risk-Aware Yield on Bitcoin Reserves

MindWave Innovations is developing institutional-grade digital asset infrastructure designed to help corporations and institutions hold, manage and generate yield from…

Chris@NNW

Frontieras North America Inc. Advances a Low-Sulfur Industrial Carbon That Heavy Industry Is Already Looking For

The challenge for steel and other heavy industries is not finding carbon; it is finding carbon that performs reliably without…

Chris@NNW

From Evaluation to Deployment: SPARC AI Inc.’s (CSE: SPAI) (OTCQB: SPAIF) Push into U.S. Public Safety with GPS-Independent Drone Technology

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI is expanding…

Chris@NNW

VERAXA Biotech AG (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase

Following completion of the initial phase of its collaboration with OmniAb, VERAXA will engineer the final VXA-222 candidate and conduct…

Chris@NNW

Frontieras North America Inc. Positions Domestic Coal as America’s Answer to Energy Supply Disruption

The United States sits on a significant coal resource base. FASForm produces six commercial outputs from a single coal input:…

Chris@NNW

Wrap Technologies Inc. (NASDAQ: WRAP) Builds Connected Public Safety Strategy as WrapShield(TM) Targets Broader Markets

WRAP is using newly raised $12 million in growth capital to support planned business expansion and accelerate development of its…

Chris@NNW

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Brings Software-First Approach to Growing Demand for GPS-Independent Navigation

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. GPS jamming and spoofing…

Chris@NNW

VERAXA Biotech AG (NASDAQ: VRXA) Builds Antibody-Based Cancer Pipeline Around Dual-Targeting Precision

VERAXA Biotech is changing how antibody-based therapies recognize and attack cancer cells, developing antibody-based cancer therapies with an emphasis on…

Chris@NNW

American Fusion(TM) Inc. (AMFN) Adds Both Commercialization and International Finance Expertise as Texatron(TM) Development Continues

American Fusion, developing commercially viable small scale fusion technology, has appointed John Gerdin as an independent director and strategic advisor,…

Chris@NNW

Market Street Capital Inc. Closing Financing Gap Behind US Manufacturing Reshoring

Many mid-market manufacturers cannot access the capital needed to build, retool or expand their facilities. A few factors tend to…

Chris@NNW